Related Experiment Videos
CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter
1Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Nature Immunology
|June 29, 2001
Summary
The class II transactivator (CIITA) drives major histocompatibility complex (MHC) class II gene expression by modifying histones. CIITA
Area of Science:
- Immunology
- Molecular Biology
- Epigenetics
Background:
- Major histocompatibility complex (MHC) class II molecules are crucial for immune responses.
- The class II transactivator (CIITA) is a key regulator of MHC class II gene expression.
- Nucleosome modifications, such as histone acetylation, play a role in gene regulation.
Purpose of the Study:
- To investigate the in vivo dynamics of MHC class II promoter assembly.
- To characterize nucleosome modifications and gene expression regulated by CIITA.
- To elucidate the role of CIITA in histone acetylation and deacetylation at the MHC class II promoter.
Main Methods:
- In vivo studies of MHC class II promoter assembly and gene expression.
- Time-course analysis of histone modifications (acetylation/deacetylation) at the HLA-DRA promoter.
- Utilized a CIITA mutant lacking the activation domain to assess specific functional roles.
Main Results:
- CIITA expression and binding correlated with temporal patterns of H3 and H4 acetylation/deacetylation at the HLA-DRA promoter.
- A CIITA mutant lacking the activation domain induced H4 acetylation but not H3 acetylation.
- H4 acetylation was localized to Lys8, suggesting involvement of specific histone acetyltransferases.
Conclusions:
- CIITA orchestrates MHC class II gene expression through dynamic nucleosome modifications.
- Distinct histone acetyltransferase activities are involved in CIITA-mediated MHC class II expression.
- H4 acetylation at Lys8 is a key event modulated by CIITA and associated factors.